Arkolith/Insider Trading/TNGX/Form 4

Third Rock Ventures GP IV, L.P.

10% OwnerTango Therapeutics, Inc. (TNGX) · full profile →Form 4 · filed Aug 26, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.1M
Net Open-Market Flow
-$2.1M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 22, 2025Sell(S)302K$7.00$2.1M15.5M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-111457) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML